Press

Treatment.com International Inc. Grants RSUs and Stock Options

By November 9, 2021 November 10th, 2021 No Comments
Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE) (OTC: TREIF) (FRA: 939), a healthcare AI technology company, announces that the Company has granted 250,000 restricted share units (the “RSUs”) and 900,000 stock options (the “Options”) to consultants of the Company. The RSUs are valid for a five-year term and are governed by the Company’s RSU Plan. The Options are exercisable at a price of $2.41 per share, valid for a five-year term and are governed by the Company’s Stock Option Plan. All RSUs and Options are subject to vesting.